Grünenthal — manufacturer's medicines
Grünenthal
Grünenthal is a German pharmaceutical company founded in 1946 in Stolberg and headquartered in Aachen. It remains a family-owned business, still held by the founding Wirtz family. Grünenthal's main focus is pain management: its portfolio includes Palexia (tapentadol), Qutenza (capsaicin patch) and Versatis (lidocaine plaster). The company also markets established medicines in other areas, including Nebido (testosterone undecanoate), which it acquired from Bayer in 2022. Grünenthal products are available in more than 100 countries.
List of medicines by manufacturer Grünenthal
✅ All products loaded (1)